Crossmark

Beneficial anti-inflammatory effects of combined rosuvastatin and cilostazol in a TNF-driven inflammatory model

Crossref DOI link: https://doi.org/10.1016/j.pharep.2018.12.005

Published Print: 2019-04

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Cho, Okki

Jang, You-jin https://orcid.org/0000-0001-6040-8145
Park, Kyung-Yeon

Heo, Tae-Hwe
Funding

Funding for this research was provided by:

Ministry of Science, Information Communication Technology (ICT) & Future Planning (NRF-2013M3A9B5075839)

Ministry of Education (ME) of Korea (22A20130012250)

ME (2018R1A6A1A03025108)

Ministry of Health and Welfare, Republic of Korea (HI16C1761)
License Information

Text and Data Mining valid from 2019-04-01
More Information

This article is maintained by: Elsevier

Article Title: Beneficial anti-inflammatory effects of combined rosuvastatin and cilostazol in a TNF-driven inflammatory model

Journal Title: Pharmacological Reports

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.pharep.2018.12.005

Content Type: article

Copyright: © 2018 Institute of Pharmacology, Polish Academy of Sciences. Published by Elsevier B.V. All rights reserved.